These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2288939)

  • 21. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole: a new drug for the treatment of acid-peptic diseases.
    Falk GW
    Cleve Clin J Med; 1991; 58(5):418-27. PubMed ID: 1934456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experience in the use of losek (omeprazole) in gastroenterology].
    Maev IV; V'iuchnova ES; Lebedev EG; Dicheva DT; Ovsiannikova EV; Antonenko OM; Shchekina MI
    Ter Arkh; 2001; 73(7):79-82. PubMed ID: 11523419
    [No Abstract]   [Full Text] [Related]  

  • 24. Oxyntic mucosa histology in omeprazole-treated patients suffering from duodenal ulcer or Zollinger-Ellison syndrome.
    Helander HF
    Digestion; 1986; 35 Suppl 1():123-9. PubMed ID: 3792669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
    Hirschowitz BI; Haber MM
    Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Criteria for use of omeprazole in adult inpatients and outpatients.
    Lajoie C
    Clin Pharm; 1992 Feb; 11(2):177-9. PubMed ID: 1551300
    [No Abstract]   [Full Text] [Related]  

  • 27. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.
    Bardram L; Thomsen P; Stadil F
    Digestion; 1986; 35 Suppl 1():116-22. PubMed ID: 3792668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omeprazole in the Zollinger-Ellison syndrome.
    Bardram L; Stadil F
    Scand J Gastroenterol; 1986 Apr; 21(3):374-8. PubMed ID: 3715402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron absorption in patients with Zollinger-Ellison syndrome treated with long-term gastric acid antisecretory therapy.
    Stewart CA; Termanini B; Sutliff VE; Serrano J; Yu F; Gibril F; Jensen RT
    Aliment Pharmacol Ther; 1998 Jan; 12(1):83-98. PubMed ID: 9692706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of long-term gastric acid suppressive therapy on serum vitamin B12 levels in patients with Zollinger-Ellison syndrome.
    Termanini B; Gibril F; Sutliff VE; Yu F; Venzon DJ; Jensen RT
    Am J Med; 1998 May; 104(5):422-30. PubMed ID: 9626024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome.
    Termanini B; Gibril F; Stewart CA; Weber HC; Jensen RT
    Aliment Pharmacol Ther; 1996 Feb; 10(1):61-71. PubMed ID: 8871445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
    Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
    Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The medical management of Zollinger-Ellison syndrome.
    Rhodes JM
    Q J Med; 1991 Mar; 78(287):191-3. PubMed ID: 1675470
    [No Abstract]   [Full Text] [Related]  

  • 34. [Omeprazole].
    Isal JP
    Gastroenterol Clin Biol; 1987 Nov; 11(11):768-80. PubMed ID: 3322924
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h.
    Hirschowitz BI; Mohnen J; Shaw S
    Aliment Pharmacol Ther; 1996 Aug; 10(4):497-506. PubMed ID: 8853753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Summary of the 34th meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee. March 15 and 16, 1989 (omeprazole and domperidone).
    Stern WR
    Am J Gastroenterol; 1989 Nov; 84(11):1351-5. PubMed ID: 2816869
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome.
    Bardram L; Stadil F
    Scand J Gastroenterol Suppl; 1989; 166():95-100; discussion 111-3. PubMed ID: 2574912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative efficacy of lansoprazole and omeprazole on the intragastric pH measured over a period of 24 hours and on the basal].
    Paul G; Ramdani A; Mignon M; Vallot T; Forestier S; Cadiot G; Ruszniewski P; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(8-9):695-701. PubMed ID: 7875436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
    Lamers CB
    Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omeprazole: effective, convenient therapy for Zollinger-Ellison syndrome.
    McArthur KE; Collen MJ; Maton PN; Cherner JA; Howard JM; Ciarleglio CA; Cornelius MJ; Jensen RT; Gardner JD
    Gastroenterology; 1985 Apr; 88(4):939-44. PubMed ID: 3972233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.